The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Non-Steroidal Anti-inflammatory Drugs Market By 2030?
The non-steroidal anti-inflammatory drugs market has experienced robust expansion over recent years. Its valuation is forecast to increase from $21.89 billion in 2025 to $23.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this market’s development has been spurred by the rising incidence of arthritis and musculoskeletal conditions, heightened recognition of pain management solutions, an expanding elderly population, the proliferation of retail pharmacy outlets, and advancements in drug creation technologies.
The non-steroidal anti-inflammatory drugs market size is projected to experience robust expansion over the coming years. It is forecast to reach $29.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected growth during the forecast period can be attributed to several factors, including the increasing adoption of personalized medicine, the expansion of e-pharmacy platforms, enhanced research and development into new NSAID formulations, the escalating occurrence of chronic inflammatory diseases, and the incorporation of digital health solutions for monitoring pain. Key trends anticipated in this period encompass tailored pain management approaches, a growing preference for over-the-counter anti-inflammatory medications, the creation of fast-acting drug formulations, an emphasis on managing chronic pain and arthritis, and the proliferation of online pharmacy services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
What Are The Main Drivers Accelerating The Growth Of The Non-Steroidal Anti-inflammatory Drugs Market?
The rising occurrence of musculoskeletal disorders is projected to fuel the expansion of the non-steroidal anti-inflammatory drug market moving forward. Musculoskeletal disorders (MSDs) encompass a wide array of conditions impacting the musculoskeletal system, including muscles, bones, tendons, ligaments, joints, and other connective tissues. Non-steroidal anti-inflammatory drugs (NSAIDs) are vital for managing pain and inflammation linked to conditions such as arthritis, osteoarthritis, and rheumatoid arthritis. Factors contributing to this market growth include an aging population, increased awareness and diagnosis of musculoskeletal disorders, orthopedic procedures, sports injuries, and the chronic nature of these conditions. For example, in January 2024, according to the GOV.UK, a UK-based government department, 18.4% of individuals aged 16 and older in 2023 reported a long-term musculoskeletal (MSK) condition, an increase from 17.6% recorded in 2022. Consequently, the increasing prevalence of musculoskeletal disorders is propelling the growth of the non-steroidal anti-inflammatory drugs market. The escalating prevalence of chronic pain is anticipated to drive the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market and associated pain management solutions in the future. Chronic pain is defined as persistent or recurring pain lasting three months or more, stemming from conditions like arthritis, fibromyalgia, back pain, neuropathic pain, and other musculoskeletal disorders. These conditions significantly impair patients’ quality of life and frequently necessitate long-term management, involving medication, physical therapy, and supportive care. The growing incidence of chronic pain increases the demand for effective pain relief therapies, such as NSAIDs and other analgesic formulations. For instance, in October 2024, the National Center for Biotechnology Information, a US-based federal government research and information organization, reported that 24.3% of adults experienced chronic pain, while 8.5% of adults reported high-impact chronic pain that restricts daily activities. Therefore, the increasing number of individuals afflicted by chronic pain is expected to boost the demand for pain management therapies, thereby supporting the growth of the NSAIDs market and related products.
How Does Segment Analysis Break Down The Non-Steroidal Anti-inflammatory Drugs Market Structure?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
What Trends Are Influencing The Future Of The Non-Steroidal Anti-inflammatory Drugs Market?
Leading companies within the non-steroidal anti-inflammatory drugs (NSAIDs) market are prioritizing the development of innovative solutions, such as combination analgesic–gastroprotective formulations. This focus aims to address the increasing demand for effective pain relief while simultaneously reducing the gastrointestinal risks commonly linked to prolonged NSAID usage. These advanced combination technologies integrate an NSAID with a protective agent, thereby maintaining anti-inflammatory efficacy and preventing stomach irritation, thus offering a safer alternative to conventional single-agent NSAIDs. For example, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. This advanced formulation combines the analgesic and anti-inflammatory effects of ibuprofen with the gastroprotective action of famotidine. This dual-action tablet is specifically designed to relieve pain while minimizing gastrointestinal side effects like ulcers or irritation, which often arise from prolonged NSAID therapy, consequently enhancing safety and improving patient adherence.
Which Industry Players Are Present In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Access The Complete Non-Steroidal Anti-inflammatory Drugs Market Report:
Which Region Is The Dominant Market In The Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Non-Steroidal Anti-inflammatory Drugs Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2026, By The Business Research Company
Non Steroidal Anti Inflammatory Drugs Market Report 2026
Anti Inflammatory Therapeutics Market Report 2026
Rheumatoid Arthritis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model